About the Project
Up to 42% of people experience hypertonicity (muscle over-activity) after brain injury. Consequences include joint contractures, pressure areas, pain, muscle weakness and tightness leading to disability, reduced quality of life and increased health care costs. Evidence suggests Botulinum toxin injections and therapy can successfully counteract these problems. Ideally patients should receive management in their local area to maximise access, support and continuity of care. We plan to make this happen by applying new knowledge of patient outcomes to the development of a best practice state-wide model of multidisciplinary hypertonicity management.
The Princess Alexandra Hospital Hypertonicity Service (PAHTS) currently provides the only specialist service in Queensland and the multidisciplinary team is the recognised state leader in the field. Unfortunately, patients from regional areas face significant access barriers.
The PAHTS has routinely collected encompassing assessment data over an eight-year period on 340 patients. The substantial database provides opportunity for a comprehensive analysis to identify patterns and trends for successful hypertonicity management in this health care setting.